Will cancer vaccine boost immunotherapy’s efficacy?
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
New neoadjuvant treatment regimen offers hope to patients facing a poor prognosis
Immune checkpoint inhibitor and oncolytic viral immunotherapy produce synergistic effect
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
irAEs are a formidable challenge
This cell surface protein could be an immune checkpoint inhibition target
Developing and delivering the care most needed by patients, now
Hope that effective therapies will soon exist for all tumor profiles